1.00
price up icon1.61%   0.0109
after-market Dopo l'orario di chiusura: .99 -0.01 -1.00%
loading

Immunic Inc Borsa (IMUX) Ultime notizie

pulisher
Apr 18, 2025

Immunic’s (IMUX) Buy Rating Reiterated at HC Wainwright - Defense World

Apr 18, 2025
pulisher
Apr 18, 2025

HC Wainwright Has Optimistic View of Immunic FY2025 Earnings - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

HC Wainwright Estimates Immunic’s Q1 Earnings (NASDAQ:IMUX) - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Immunic, Inc. (NASDAQ:IMUX) Is Expected To Breakeven In The Near Future - simplywall.st

Apr 16, 2025
pulisher
Apr 11, 2025

Immunic Stock Price, Quotes and Forecasts | NASDAQ:IMUX - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Immunic, Inc. Announces Closing of $5.1 Million Registered Direc - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode - MSN

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - The Malaysian Reserve

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic Closes of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - citybiz

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - Eastern Progress

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic Raises $5.1 Million From Direct Stock Offering - marketscreener.com

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic Lands Strategic $5.1M Financing Deal: Aberdeen Investments Takes Lead Position - Stock Titan

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic closes $5.1M placement - Proactive financial news

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic announces pricing of $5.1M registered direct offering - MSN

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic, Inc. Announces Pricing of $5.1 Million Registered Direc - GuruFocus

Apr 10, 2025
pulisher
Apr 10, 2025

Immunic Announces $5.1 Million Securities Purchase Agreement - MSN

Apr 10, 2025
pulisher
Apr 09, 2025

Immunic sets $5.1 million stock offering price By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

Immunic sets $5.1 million stock offering price - Investing.com Australia

Apr 09, 2025
pulisher
Apr 09, 2025

Immunic announces pricing of $5.1M direct offering to support clinical pipeline - Proactive financial news

Apr 09, 2025
pulisher
Apr 09, 2025

Immunic Announces Pricing Of $5.1 Million Registered Direct Offering - marketscreener.com

Apr 09, 2025
pulisher
Apr 09, 2025

Immunic Lands $5.1M Institutional Backing: Aberdeen Investments Takes Major Stake - Stock Titan

Apr 09, 2025
pulisher
Apr 05, 2025

What is Leerink Partnrs’ Estimate for Immunic Q1 Earnings? - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Immunic (NASDAQ:IMUX) Earns “Buy” Rating from D. Boral Capital - The AM Reporter

Apr 03, 2025
pulisher
Apr 02, 2025

Immunic (NASDAQ:IMUX) Given “Buy” Rating at D. Boral Capital - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Immunic to present at AAN 2025 and German Biotech Days in April - Proactive financial news

Apr 02, 2025
pulisher
Apr 01, 2025

Immunic, Inc. to Participate in Scientific and Industry Conferences in April - The Malaysian Reserve

Apr 01, 2025
pulisher
Apr 01, 2025

Immunic's Game-Changing MS Treatment Takes Center Stage at Two Global Conferences - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

IMMUNIC, INC. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Immunic CMO discusses significance of MS Awareness Month; progress with treatment - Proactive financial news

Mar 31, 2025
pulisher
Mar 31, 2025

Immunic, Inc. (NASDAQ:IMUX) Receives $12.67 Average PT from Brokerages - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Immunic Therapeutics: Interview With CEO Dr. Daniel Vitt About The Inflammatory And Autoimmune Diseases Therapy Company - Pulse 2.0

Mar 28, 2025
pulisher
Mar 28, 2025

180 Life Sciences (NASDAQ:ATNF) versus Immunic (NASDAQ:IMUX) Head to Head Comparison - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

Immunic (NASDAQ:IMUX) Now Covered by Analysts at William Blair - Defense World

Mar 26, 2025
pulisher
Mar 26, 2025

Immunic (NASDAQ:IMUX) Now Covered by William Blair - The AM Reporter

Mar 26, 2025
pulisher
Mar 25, 2025

William Blair Initiates Coverage of Immunic (IMUX) with Outperform Recommendation - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

William Blair sees Immunic stock outperforming on RMS therapy By Investing.com - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

How did Immunic Inc (IMUX) fare last session? - uspostnews.com

Mar 25, 2025
pulisher
Mar 25, 2025

William Blair sees Immunic stock outperforming on RMS therapy - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Companies Like Immunic (NASDAQ:IMUX) Could Be Quite Risky - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

William Blair Initiates Immunic at Outperform With $6.80 Price Target - MarketScreener

Mar 25, 2025
pulisher
Mar 24, 2025

Buy Rating on Immunic Driven by Promising CALLIPER Study Outcomes and Market Opportunities in Progressive Multiple Sclerosis - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Immunic’s Vidofludimus Calcium: A Promising Disruptor in the $45 Billion Multiple Sclerosis Market - TipRanks

Mar 24, 2025
pulisher
Mar 20, 2025

StockNews.com Downgrades Immunic (NASDAQ:IMUX) to Sell - Defense World

Mar 20, 2025
pulisher
Mar 14, 2025

Immunic provides MS research update – ICYMI - Proactive Investors Australia

Mar 14, 2025
pulisher
Mar 14, 2025

Immunic (NASDAQ:IMUX) Raised to “Hold” at StockNews.com - Defense World

Mar 14, 2025
$20.27
price up icon 0.92%
$71.24
price up icon 2.53%
$32.19
price up icon 0.11%
$27.35
price up icon 8.52%
$104.68
price up icon 2.82%
biotechnology ONC
$252.77
price up icon 10.52%
Capitalizzazione:     |  Volume (24 ore):